Journal of Hepatology
Volume 53, Issue 2 , Pages 372-384, August 2010

A position statement on NAFLD/NASH based on the EASL 2009 special conference☆

  • Vlad Ratziu

      Affiliations

    • Université Pierre et Marie Curie Paris VI, Assistance Publique Hôpitaux de Paris, INSERM UMRS 893, France
    • ,
  • Stefano Bellentani

      Affiliations

    • Centro Studi Fegato, Gastroenterologia, Distretto di Carpi, Azienda USL di Modena, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 059371102; fax: +39 059851762.
    • ,
  • Helena Cortez-Pinto

      Affiliations

    • Departamento de Gastrenterologia, Unidade de Nutrição e Metabolismo, Hospital Universitário de Santa Maria, Instituto de Medicina Molecular, Lisbon, Portugal
    • ,
  • Chris Day

      Affiliations

    • Institute of Cellular Medicine, Newcastle University, Newcastle Upon Tyne, United Kingdom
    • ,
  • Giulio Marchesini

      Affiliations

    • Alma Mater Studiorum, Unit of Metabolic Diseases and Clinical Dietetics, University of Bologna, Italy

Received 11 March 2010; accepted 2 April 2010. published online 07 May 2010.

Keywords: Nonalcoholic fatty liver disease, Nonalcoholic steatohepatitis, Steatosis, Fibrosis, Insulin resistance, Mortality, Guidelines, Diagnosis, Treatment

No abstract is available. To read the body of this article, please view the Full Text online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

☆ This position statement has been endorsed by the European Association for the Study of the Liver, and it is a summary of “NAFLD/NASH and Related Metabolic Disease” EASL Special Conference, held in Bologna, September 24–26, 2009.

PII: S0168-8278(10)00414-9

doi:10.1016/j.jhep.2010.04.008

Journal of Hepatology
Volume 53, Issue 2 , Pages 372-384, August 2010

Article Tools